Ashely Claudino is an Evergreen Staff Writer from Portugal. She has a Translation degree from the University of Lisbon (2020, Faculty of Arts and Humanities). Nowadays, she mostly writes Fortnite and ...

The FDA approved Evrysdi in 2020 and has treated over 21,000 patients worldwide. In 2024, Evrysdi generated sales of approximately 1.6 billion Swiss francs ($1.9 billion), representing 18% ...

Royalty Pharma will begin receiving the increased royalty payments in the first quarter of 2026, based on Evrysdi sales from the fourth quarter of 2025. With a beta of just 0.46, Royalty Pharma offers ...

Uranium Royalty Corp. operates as a pure-play uranium royalty company in Canada, the United States, Namibia, and Spain. It engages in the acquisition and assembly of a portfolio of royalties; ...

Empress Royalty Corp. engages in creating and investing in a portfolio of precious metal royalty and streaming interests in Canada. It focuses on small to mid-tier producing or development stage ...

The world is a magnificent canvas, bursting with an infinite spectrum of colours. Colours are not just science, but they also carry deep cultural meanings and famous nicknames. For instance, Red is ...

As King Charles enters 2026 with a reduced treatment plan for his cancer, the monarch will be embracing the busy year ahead with a renewed sense of energy and his trademark diligence. He and his wife ...

It's been quite the rollercoaster of a year for the British royal family, with ups and downs at every corner. Perhaps the most shocking moment for the monarchy was the King's decision to strip his ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Empress Royalty Corp. is a new precious metals royalty and streaming creation company with a portfolio of precious metals royalties. It focuses on investing in development and production stage ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.